CD19 and neoplasm: Garg et al. used IHC for CD20 in tumor tissue, and single-cell mRNA expression of CD19/CD20 in primary cutaneous melanomas of > 1 mm Breslow thickness to demonstrate that higher CD20 staining and higher CD19/20 mRNA was associated with primary tumors that did not metastasize [23].